Market Cap 135.19B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 7.95
Forward PE 8.15
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 38,181,252
Avg Vol 42,427,867
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 30%
Beta 0.35
Analysts Sell
Price Target $29.05

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
MrPeanutEsquire
MrPeanutEsquire Jul. 8 at 11:48 PM
$PFE Cramer has switched from bearish to bullish 5 or 6 times in the last year and a half since ive owned this stock. But now he says he has given up on us. This might be a very good sign!
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 8 at 11:25 PM
$SLS $ABBV this $2.6B manipulated mcap will be worth $40B to big pharma $LLY $ABBV $PFE the instant Gps Phase 3 registrational results are announced. $2.6B /$13.5 per share will be worth $40B / $200 per share all day.
0 · Reply
LUNR_SpacEx_onSteroids
LUNR_SpacEx_onSteroids Jul. 8 at 11:23 PM
$CMPS ✅👍✅👍✅👍✅ $70. Says HC Weinwright 👍 Analysts currently have a consensus "Strong Buy" to "Moderate Buy" rating on COMPASS Pathways, with an average 12-month price target of approximately $22.88 to $24.15. Projections from Wall Street firms range from a low of $8.00 to a high street target of $70.00. [1, 2, 3] Following positive Phase 3 and durability data regarding its COMP360 psilocybin therapy for treatment-resistant depression, several major firms updated their ratings and price targets for COMPASS Pathways in July 2026: [1, 2, 3] * BTIG: Maintained a "Buy" rating and raised their price target to $25.00 (from $14.00). * Stifel: Maintained a "Buy" rating and raised their price target to $21.00 (from $14.00). * Oppenheimer: Maintained an "Outperform" rating with a price target of $20.00. * ✅HC Wainwright : Reiterated BUY rating and raised Maintains a $70 price target * ( Source Schwab; Benzinga News Wire ) Sure beats $LLY and $PFE
0 · Reply
thebrockettman
thebrockettman Jul. 8 at 9:56 PM
$PFE Everyday is pain
0 · Reply
ItsCarRamRod
ItsCarRamRod Jul. 8 at 9:49 PM
$PFE today was the best day PFE has had in almost 4 weeks. ROFL
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 9:19 PM
$PFE Homegamers...... Have A Good Evening. Hopefully This Timmmmmberrrs Again In The AM..... I'm 'ITCHING'.... To Get Back In At.......$23.70 !
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Jul. 8 at 9:15 PM
0 · Reply
inv1ncible
inv1ncible Jul. 8 at 8:52 PM
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 8:05 PM
$PFE IT'S GREEN ! Oh, AH.... Nevermind......
1 · Reply
breakawayrider
breakawayrider Jul. 8 at 8:02 PM
$PFE Phew…that was close…i didn’t think we were going to be able to close red… Actually traded better than most other big cap pharma..
1 · Reply
Latest News on PFE
Pfizer price target lowered to $28 from $30 at JPMorgan

2026-07-08T12:15:37.000Z - 12 hours ago

Pfizer price target lowered to $28 from $30 at JPMorgan


Pfizer (PFE) Stock Bounces Back After an Analyst Downgrade

2026-07-07T15:54:25.000Z - 1 day ago

Pfizer (PFE) Stock Bounces Back After an Analyst Downgrade


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 2 days ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer downgraded to Hold from Buy at HSBC

2026-07-06T09:50:29.000Z - 2 days ago

Pfizer downgraded to Hold from Buy at HSBC


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 14 days ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 14 days ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 20 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 20 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 20 days ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 4 weeks ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 4 weeks ago

Pfizer Press release: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 5 weeks ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 2 months ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 2 months ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 2 months ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 2 months ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 2 months ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 2 months ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 2 months ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


MrPeanutEsquire
MrPeanutEsquire Jul. 8 at 11:48 PM
$PFE Cramer has switched from bearish to bullish 5 or 6 times in the last year and a half since ive owned this stock. But now he says he has given up on us. This might be a very good sign!
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 8 at 11:25 PM
$SLS $ABBV this $2.6B manipulated mcap will be worth $40B to big pharma $LLY $ABBV $PFE the instant Gps Phase 3 registrational results are announced. $2.6B /$13.5 per share will be worth $40B / $200 per share all day.
0 · Reply
LUNR_SpacEx_onSteroids
LUNR_SpacEx_onSteroids Jul. 8 at 11:23 PM
$CMPS ✅👍✅👍✅👍✅ $70. Says HC Weinwright 👍 Analysts currently have a consensus "Strong Buy" to "Moderate Buy" rating on COMPASS Pathways, with an average 12-month price target of approximately $22.88 to $24.15. Projections from Wall Street firms range from a low of $8.00 to a high street target of $70.00. [1, 2, 3] Following positive Phase 3 and durability data regarding its COMP360 psilocybin therapy for treatment-resistant depression, several major firms updated their ratings and price targets for COMPASS Pathways in July 2026: [1, 2, 3] * BTIG: Maintained a "Buy" rating and raised their price target to $25.00 (from $14.00). * Stifel: Maintained a "Buy" rating and raised their price target to $21.00 (from $14.00). * Oppenheimer: Maintained an "Outperform" rating with a price target of $20.00. * ✅HC Wainwright : Reiterated BUY rating and raised Maintains a $70 price target * ( Source Schwab; Benzinga News Wire ) Sure beats $LLY and $PFE
0 · Reply
thebrockettman
thebrockettman Jul. 8 at 9:56 PM
$PFE Everyday is pain
0 · Reply
ItsCarRamRod
ItsCarRamRod Jul. 8 at 9:49 PM
$PFE today was the best day PFE has had in almost 4 weeks. ROFL
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 9:19 PM
$PFE Homegamers...... Have A Good Evening. Hopefully This Timmmmmberrrs Again In The AM..... I'm 'ITCHING'.... To Get Back In At.......$23.70 !
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Jul. 8 at 9:15 PM
0 · Reply
inv1ncible
inv1ncible Jul. 8 at 8:52 PM
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 8:05 PM
$PFE IT'S GREEN ! Oh, AH.... Nevermind......
1 · Reply
breakawayrider
breakawayrider Jul. 8 at 8:02 PM
$PFE Phew…that was close…i didn’t think we were going to be able to close red… Actually traded better than most other big cap pharma..
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 8 at 8:00 PM
$PFE 🫩🫩🫩
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 8 at 7:59 PM
$PFE miserable POS
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 7:59 PM
$PFE BINGO !
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 7:58 PM
$PFE RUT RO.........
0 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 8 at 7:54 PM
$PFE it never changes
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jul. 8 at 7:45 PM
$PFE @MrPeanutEsquire
1 · Reply
jack1342
jack1342 Jul. 8 at 7:30 PM
$PFE always sells off
0 · Reply
Mithlorien
Mithlorien Jul. 8 at 7:29 PM
$PFE Come to me 23$, I want you
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jul. 8 at 7:22 PM
$PFE Im afraid im going to have to lower my price target on Pfizer from whatever the stock was last week to whatever the stock is this week. Hopefully I can raise my price target soon but im going to need to see some upward movement in the stock price before I can do that. Stay tuned for updates!
1 · Reply
Micheal_Pothead
Micheal_Pothead Jul. 8 at 7:10 PM
$PFE typical
0 · Reply
DivvyInvestor
DivvyInvestor Jul. 8 at 7:02 PM
$PFE Come on Back To $23.70 PFE... Ur DADDY Wants Back IN !
1 · Reply
CADev21
CADev21 Jul. 8 at 6:51 PM
$PFE I'll grab 300 shares here to start.
0 · Reply